Celularity
CELU
17 hedge funds and large institutions have $105M invested in Celularity in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
3.67% more ownership
Funds ownership: 0% → 3.67% (+3.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
+$24.7M |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$21.6M |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$19.6M |
| 4 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
+$7.36M |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$6.87M |
Top Sellers
CELU Hedge Fund Activity: Q3 2019 in Review
17 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q3 2019, worth a combined $105M.
Buyers outnumbered sellers: 17 funds opened new CELU positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Linden Advisors, opening a new position worth an estimated $24.7M.
- 17 institutional investors held Celularity (CELU) as of Q3 2019, up from 0 in Q2 2019.
- Funds reported $105M of Celularity stock for Q3 2019.
- 17 funds opened new Celularity positions in Q3 2019 and 0 closed out, a net change of +17 holders.
- The largest Celularity buyer in Q3 2019 was Linden Advisors, an estimated $24.7M added.
Based on aggregated 13F filings for Q3 2019.